Literature DB >> 9237625

A recombinant polypeptide model of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator functions as an active ATPase, GTPase and adenylate kinase.

C Randak1, P Neth, E A Auerswald, C Eckerskorn, I Assfalg-Machleidt, W Machleidt.   

Abstract

CFTR-NBF-2 expressed and purified in fusion with the maltose-binding protein was shown to catalyse the reaction ATP-->ADP+Pi by three different assays, monitoring ATP turnover, formation of ADP and release of Pi (Km 86 microM, rate constant 0.37 min(-1)). The reaction product ADP inhibits this ATPase activity. In a similar manner the hydrolysis of GTP to GDP and Pi was demonstrated (Km 40 microM, rate constant 0.29 min(-1)). In the presence of AMP the ATPase reaction was superseded by the formation of two ADP from ATP and AMP. As typical for adenylate kinases a distinct AMP-binding site could be verified for CFTR-NBF-2 by the inability of TNP-ATP and AMP to compete for binding. All three enzymatic activities were inhibited by the symmetric double-substrate-mimicking inhibitor Ap5A. As NBF-2 plays a central role in CFTR channel opening and closing the results reported here are fundamental in understanding mechanisms of CFTR channel activity regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237625     DOI: 10.1016/s0014-5793(97)00574-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

Review 1.  CFTR channel gating: incremental progress in irreversible steps.

Authors:  L Csanády; D C Gadsby
Journal:  J Gen Physiol       Date:  1999-07       Impact factor: 4.086

2.  Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.

Authors:  C Randak; E A Auerswald; I Assfalg-Machleidt; W W Reenstra; W Machleidt
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 3.  Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

4.  A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating.

Authors:  Qian Dong; Christoph O Randak; Michael J Welsh
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

5.  Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein.

Authors:  C Wang; A F Castro; D M Wilkes; G A Altenberg
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

6.  Voltage-dependent flickery block of an open cystic fibrosis transmembrane conductance regulator (CFTR) channel pore.

Authors:  Z Zhou; S Hu; T C Hwang
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

Review 7.  CFTR (ABCC7) is a hydrolyzable-ligand-gated channel.

Authors:  Andrei A Aleksandrov; Luba A Aleksandrov; John R Riordan
Journal:  Pflugers Arch       Date:  2006-09-26       Impact factor: 3.657

8.  ADP inhibits function of the ABC transporter cystic fibrosis transmembrane conductance regulator via its adenylate kinase activity.

Authors:  Christoph O Randak; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

9.  Status of fluid and electrolyte absorption in cystic fibrosis.

Authors:  M M Reddy; M Jackson Stutts
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 10.  Role of CFTR's intrinsic adenylate kinase activity in gating of the Cl(-) channel.

Authors:  Christoph O Randak; Michael J Welsh
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.